Results 21 to 30 of about 14,172 (227)

Next-generation sequencing to characterise pyrazinamide resistance in Mycobacterium tuberculosis isolates from two Balkan countries [PDF]

open access: yesJournal of Global Antimicrobial Resistance, 2022
: Objectives: Next-generation sequencing (NGS) can provide a comprehensive analysis of the genetic alterations most commonly linked with pyrazinamide (PZA) resistance. However, there are no studies reporting the molecular background of PZA resistance in
Eva Sodja   +4 more
doaj   +3 more sources

Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis [PDF]

open access: yesAntimicrobial Agents and Chemotherapy, 2021
Samuel J Modlin   +2 more
exaly   +2 more sources

Detection of Mycobacterium Tuberculosis Resistance to Pyrazinamide Antibiotic Using Polymerase Chain Reaction (PCR) Technique [PDF]

open access: diamond, 2022
The tuberculosis treatment control program is constrained by the outbreak of TB that is resistant to anti-tuberculosis drugs (OAT), especially multidrug-resistant tuberculosis.
Edy Kurniawan, Idham Halid
openalex   +3 more sources

Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifampicin and fluoroquinolone resistance. [PDF]

open access: yesThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2015
Multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains of Mycobacterium tuberculosis (TB) constitute a major public health concern.To determine the timing of pncA mutations that confer pyrazinamide (PZA) resistance in relation to mutations conferring resistance to isoniazid (INH) and rifampicin (RMP).Isolates from two major urban ...
A. K. Alame-Emane   +9 more
openaire   +4 more sources

First-line drug-resistant tuberculosis among children under 15 years in Ethiopia: insights from phenotypic and whole-genome sequencing approaches [PDF]

open access: yesBMC Infectious Diseases
Background Childhood drug-resistant tuberculosis is often underdiagnosed and inadequately characterized due to the paucibacillary nature of the disease.
Yeshiwork Abebaw   +11 more
doaj   +2 more sources

Pyrazinamide Resistance and pncA Mutation Profiles in Multidrug Resistant Mycobacterium Tuberculosis. [PDF]

open access: yesInfect Drug Resist, 2022
Pyrazinamide (PZA) is a critical component of standardized chemotherapy for tuberculosis (TB) and is recommended for the treatment of multidrug-resistant (MDR) TB. We aimed to characterize mutations in pncA of M. tuberculosis and evaluate their diagnostic accuracy for PZA susceptibility in China.
Shi D, Zhou Q, Xu S, Zhu Y, Li H, Xu Y.
europepmc   +5 more sources

Comparative Performance of Genomic Methods for the Detection of Pyrazinamide Resistance and Heteroresistance in Mycobacterium tuberculosis. [PDF]

open access: yesJ Clin Microbiol, 2022
: Pyrazinamide is an important component of both drug-susceptible and drug-resistant tuberculosis treatment regimens. Although approximately 50% of rifampin-resistant isolates are also resistant to pyrazinamide, pyrazinamide susceptibility testing is not
Whitfield MG   +8 more
europepmc   +3 more sources

Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance [PDF]

open access: green, 2011
Pyrazinamide is one of the most important drugs in the treatment of latent Mycobacterium tuberculosis infection. The emergence of strains resistant to pyrazinamide represents an important public health problem, as both first- and second-line treatment ...
Mirko Zimic   +5 more
openalex   +3 more sources

Home - About - Disclaimer - Privacy